Role of robot‐assisted radical prostatectomy in locally advanced prostate cancer

Sakaguchi, Takashi; Miura, Noriyoshi; Fukumoto, Takumi; Yanagihara, Yoshio; Miyauchi, Yuhei; Kikugawa, Tadahiko

doi:10.1111/iju.13441

Cited by 49 publications

(42 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prostate cancer became the most prevalent male cancer in 2016, and still, the number continues to increase in Japan. 1 In contrast, in the USA, the number of prostate cancer patients has continued to decrease since 1992. The exposure rate of prostate-specific antigen (PSA) screening might be responsible for the difference in trends between the two countries.…”

Section: Conflict Of Interestmentioning

confidence: 99%

“…However, remarkable racial and ethnic differences in the incidence have been reported, ranging from 4.4 per 100 000 to 118.2 per 100 000 persons in India and the USA, respectively. Additionally, it represents the second most common cause of cancer‐related mortality in the USA and Europe . The incidence of PCa has been increasing worldwide in recent years.…”

Section: Introductionmentioning

confidence: 99%

“…Additionally, it represents the second most common cause of cancer-related mortality in the USA and Europe. 1,2 The incidence of PCa has been increasing worldwide in recent years. This trend has been growing even in Asian countries, particularly in northeast Asian countries.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Epidemiology of prostate cancer in Asian countries

2018

View full text Add to dashboard Cite

The incidence of prostate cancer has been increasing worldwide in recent years. The GLOBOCAN project showed that prostate cancer was the second most frequently diagnosed cancer and the fifth leading cause of cancer mortality among men worldwide in 2012. This trend has been growing even in Asian countries, where the incidence had previously been low. However, the accuracy of data about incidence and mortality as a result of prostate cancer in some Asian countries is limited. The cause of this increasing trend is multifactorial. One possible explanation is changes in lifestyles due to more Westernized diets. The incidence is also statistically biased by the wide implementation of early detection systems and the accuracy of national cancer registration systems, which are still immature in most Asian countries. Mortality rate decreases in Australia, New Zealand and Japan since the 1990s are possibly due to the improvements in treatment and/or early detection efforts employed. However, this rate is increasing in the majority of other Asian countries. Studies of latent and incidental prostate cancer provide less biased information. The prevalence of latent and incidental prostate cancer in contemporary Japan and Korea is similar to those in Western countries, suggesting the influence of lifestyle changes on carcinogenesis. Many studies reported evidence of both congenital and acquired risk factors for carcinogenesis of prostate cancer. Recent changes in the acquired risk factors might be associated with the increasing occurrence of prostate cancer in Asian countries. This trend could continue, especially in developing Asian countries.

show abstract

Section: Conflict Of Interestmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology of prostate cancer in Asian countries

2018

View full text Add to dashboard Cite

show abstract

“…RARP has been increasingly accepted as a surgical treatment option for younger and healthier patients with localized prostate cancer over the last decade 16 , 17 . RARP achieves consistent oncological outcomes and is associated with a low risk of complications 18 , 19 .…”

Section: Discussionmentioning

confidence: 99%

Robot-assisted radical prostatectomy with clipless intrafascial neurovascular bundle-sparing approach: surgical technique and one-year functional and oncologic outcomes

Shin

Lee

2020

Sci Rep

View full text Add to dashboard Cite

Various neurovascular bundle-sparing techniques have been introduced to maximize recovery of erectile function after robot-assisted radical prostatectomy (RARP). The clipless intrafascial neurovascular bundle-sparing technique aims to preserve periprostatic structures and neurovascular bundles as much as possible by avoiding clipping of the vascular pedicles. This study reports 1-year functional and oncologic outcomes and postoperative complications in 105 patients with intact preoperative erectile function who underwent a modified clipless intrafascial neurovascular bundle-sparing RARP. Intact erectile function was defined as score ≥ 21 on the Sexual Health Inventory for Men questionnaire or ability to have sexual intercourse. Median follow-up was 26.5 months (IQR 15.25–48). Postoperative erectile function recovery rates were 71.4%, 81.9%, 88.6%, 92.4%, and 94.3% at 1, 3, 6, 9, and 12 months, respectively. The rate of positive surgical margins was 16.2% overall and 11.8% in patients with stage pT2 disease. The biochemical recurrence rate was 6.7% overall. The modified clipless intrafascial neurovascular bundle-sparing technique is safe and feasible and can achieve excellent recovery of erectile function after RARP. Further large-scale prospective comparative studies are warranted.

show abstract

“…In Western and Northern Europe, more than 200 men per 100,000 receive a diagnosis of prostate cancer (PCa) every year [1], making it the most common cancer in European men after skin cancer [2]. In addition, PCa is the second most common cause of cancer-related mortality among men in Europe and the USA [3,4]. This is coupled with a notable psychological impact.…”

Section: Introductionmentioning

confidence: 99%

Patients’ experience with MRI-guided in-bore biopsy versus TRUS-guided biopsy in prostate cancer: a pilot study

Pizzoli

Marton

Pricolo

et al. 2020

ecancer

View full text Add to dashboard Cite

Background: Ultrasound-guided magnetic resonance imaging (MRI)-fusion biopsy and in-bore MRI-guided biopsy (MRGB) have improved the diagnostic pathway in patients with suspected prostate cancer compared to the traditional random sampling of the prostate gland under transrectal ultrasound guidance (TRUS-Bx). The aim of our study was to assess the psychological experiences of patients undergoing MRGB and TRUS-Bx. Method: Participants completed an ad hoc set of 11 items to be rated from 0 (not at all) to 10 (very much) on visual analogue scales and one open question on the most worrisome aspect of the procedure. The set of items evaluated satisfaction with the information received and the possibility to ask questions to the staff; the tolerability of the irritation, duration and discomfort associated with the exam; their level of worry or calm before the exam; the perceived need to undergo the exam; their satisfaction with the exam and willingness to repeat it in the future; and acceptability of the exam. Results: Between May 2018 and June 2019, 47 participants were enrolled on the day of their MRGB; 24 had previously undergone TRUS-Bx. The MRGB was rated with high positive scores on all 11 items. The lowest ratings regarded the duration of the exam (mean = 6.6) and feeling calm (mean = 6.6). Participants were significantly more satisfied with MRGB than TRUS-Bx, rating it as less painful and more comfortable, necessary and tolerable. Conclusion: These preliminary results indicate that the MRGB is likely to be more tolerable and acceptable to patients than TRUS-Bx.

show abstract

Role of robot‐assisted radical prostatectomy in locally advanced prostate cancer

Cited by 49 publications

References 63 publications

Epidemiology of prostate cancer in Asian countries

Epidemiology of prostate cancer in Asian countries

Robot-assisted radical prostatectomy with clipless intrafascial neurovascular bundle-sparing approach: surgical technique and one-year functional and oncologic outcomes

Patients’ experience with MRI-guided in-bore biopsy versus TRUS-guided biopsy in prostate cancer: a pilot study

Contact Info

Product

Resources

About